Documents to download

World Cancer Day has been marked on 4 February each year since 2000, when it was established at the World Summit Against Cancer for the New Millennium held in Paris that year. It is an initiative of the Union for International Cancer Control (UICC), a membership organisation of over 950 organisations in more than 150 countries that works to reduce the global cancer burden, promote greater equity and integrate cancer control into the world health and development agenda. The initiative is supported by the World Health Organisation (WHO) and International Agency for Research on Cancer (IARC).

The theme for World Cancer Day 2016–18 is ‘We can. I can’. The UICC has stated that events taking place in this cycle will explore how “everyone—as a collective or as individuals—can do their part to reduce the global burden of cancer”.

In 2016, the United Nations outlined the following information as part of its campaign to support the World Cancer Day initiative: 

  • Cancer is a leading cause of death worldwide, accounting for 8.2 million deaths in 2012.
  • Lung, stomach, liver, colon and breast cancer cause the most cancer deaths each year.
  • The most frequent types of cancer differ between men and women.
  • About 30 percent of cancer deaths are due to the five leading behavioural and dietary risks: high body mass index, low fruit and vegetable intake, lack of physical activity, tobacco use, alcohol use.
  • Tobacco use is the most important risk factor for cancer causing 22 percent of global cancer deaths and 71 percent of global lung cancer deaths.
  • Cancer causing viral infections such as HBV/HCV and HPV are responsible for up to 20 percent of cancer deaths in low and middle income countries.
  • About 70 percent of all cancer deaths in 2008 occurred in low and middle income countries.
  • Deaths from cancer worldwide are projected to continue rising, with an estimated 13.1 million deaths in 2030.

The most recent statistical bulletin on cancer registration statistics published by the Office for National Statistics included the following main findings relating to cancer registrations in England in 2014: 

  • The number of new cancer registrations in England was 296,863 in 2014; an increase of 4,183 registrations from the same point in 2013.
  • More cancers were registered in males (150,832) than females (146,031). Across the majority of cancer sites more males are diagnosed with cancer than females. This is a persistent feature of the data, reported in previous registration years.
  • The age-standardised incidence rates for newly diagnosed cancers were 670.8 per 100,000 males and 546.1 per 100,000 females. The rate takes into account the different age structures between males and females.
  • Breast (15.6 percent), prostate (13.4 percent), lung (12.6 percent) and colorectal (11.5 percent) cancer continue to account for over half of the malignant cancer registrations in England for all ages combined.
  • Cancer is a disease of the elderly, as approximately 12 percent of the population are aged 70 and above and account for 50.2 percent of the total cancers registered in 2014.
  • Generally, the cancer incidence rates increase over time, while mortality rates decrease, reflecting the general increase in cancer survival as reported in the latest cancer survival estimates.

Documents to download

Related posts

  • Infected blood scandal: Background, impacts, inquiry outcomes and compensation

    Between 1970 and the early 1990s, over 30,000 NHS patients were given blood transfusions, or treatments made using blood products, which were contaminated with hepatitis C or HIV. Over 3,000 people have since died, and thousands more live with health conditions. The infected blood inquiry called for immediate compensation, public memorials, and for lessons to be learned in medicine, government and the civil service. In August 2024 the government set out plans for compensation.

    Infected blood scandal: Background, impacts, inquiry outcomes and compensation
  • Vaginal mesh implants: Financial compensation

    Vaginal mesh implants are used to repair damaged internal tissue. However, many women receiving these implants have experienced severe complications. In 2020, an independent review recommended establishing a compensation scheme for the women affected. The Conservative government rejected this recommendation, saying its focus would be on improving product safety. However, calls for redress have continued, with a subsequent review in 2024 also recommending the establishment of a compensation scheme.

    Vaginal mesh implants: Financial compensation